Reactions 1680, p304 - 2 Dec 2017 Paradoxical psoriasis: 2 case reports In a monocentric retrospective observational study of five patients, a 37-year-old woman and a 46-year-old woman developed paradoxical psoriasis during treatment with ustekinumab (1 patient) or secukinumab (1 patient) [routes and outcomes not stated]. Patient 1: A 37-year-old woman, who was diagnosed with SAPHO syndrome characterised by palmoplantar pustulosis since three years, received treatment with ustekinumab 90mg. Subsequently, she developed paradoxical psoriasis. After six months of the treatment, ustekinumab was discontinued. Patient 2: A 46-year-old woman, who was diagnosed with SAPHO syndrome characterised by palmoplantar pustulosis since five years, received treatment with secukinumab 150mg. Subsequently, she developed paradoxical psoriasis. After three months of the treatment, secukinumab was discontinued. Author comment: "No particular safety concerns were reported, except cases of paradoxical psoriasis flare(contributing to discontinuation of treatment) in one under ustekinumab, and the other case under secukinumab." Wendling D, et al. IL-23/Th17 targeted therapies in SAPHO syndrome. A case series. Joint Bone Spine 84: 733-735, No. 6, Dec 2017. Available from: URL: https://doi.org/10.1016/j.jbspin.2017.05.016 - France 803284087 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud